Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of simulation and modeling software to the pharmaceutical industry, announces the appointment of Mr. John DiBella as manager of marketing and sales, reporting to Dr. Michael Pelekis, director of business development, marketing, and sales.

Walt Woltosz, chairman and chief executive officer of Simulations Plus, said: “Mr. Ronald Creeley, former vice president of marketing and sales, has resigned as of the end of this month. Mr. DiBella has been with Simulations Plus for over six years, four of those in marketing and sales, and has done an outstanding job in demonstrating the products as well as the more difficult task of training new users in how to get the most from them. John holds a master’s degree in biomedical engineering from CaseWestern ReserveUniversity. He was the original developer of our DDDPlus™ simulation software program, the only program available for simulating in vitro dissolution experiments. John’s strong engineering and science background, in-depth knowledge of our products and services, and business acumen developed from more than four years in sales, bring a new dimension to the leadership of our marketing and sales efforts.”

Mr. DiBella added: “I’m excited to have this opportunity to lead our marketing and sales efforts. After the transition from developing our DDDPlus simulation software product, I wanted to work more in direct customer contact. Simulations Plus gave me the opportunity to move into marketing and sales, becoming the company’s first full-time salesperson, and I have enjoyed it thoroughly. Simulations Plus is in an enviable position with best-in-class products and an outstanding reputation for good science and excellent software. I look forward to working with the rest of the talented Simulations Plus staff to increase our market penetration and growth rate.”